📣 On European #VonWillebrandDisease Awareness Day, we're highlighting a critical gap: #VonWillebrandFactor is absent from the EU #CriticalMedicine List. 🇪🇺This threatens patient safety & must be addressed urgently. Read more 👉 tinyurl.com/5277aby7

#VWDay

@stinebosse.bsky.social

EHC urges EU to add von Willebrand Factor to Critical Medicines List • European Haemophilia Consortium (EHC) EHC is calling on the European Medicines Agency to include von Willebrand Factor in the Union List of Critical Medicines, highlighting the urgent need to protect patients with von Willebrand Disease.

📣 People with #VonWillebrandDisease rely on #VonWillebrandFactor (VWF) to live safely — yet supply remains fragile. We urge National Competent Authorities to classify VWF as a #CriticalMedicine to protect patient access across Europe.

www.ehc.eu/news/ehc-urg...

#VonWillebrandDisease affects up to 1% of people but is often overlooked. Delays in #VonWillebrandFactor supply can be dangerous - healthcare systems must recognise VWF as a #CriticalMedicine.

@ema.europa.eu

#CriticalCare #BleedingDisorders

Without access to #VonWillebrandFactor (VWF), people with #VonWillebrandDisease face significant limitations preventing life-threatening bleeding. Healthcare systems must recognise VWF as #CriticalMedicine 📣

@ema.europa.eu

#CriticalCare #BleedingDisorders

The recognition of #VonWillebrandFactor as a #CriticalMedicine is a decision based on evidence, equity and medical urgency.

@ema.europa.eu

#VonWillebrandDisease #CriticalCare #BleedingDisorders

It's time for health systems to recognise #VonWillebrandFactor as a #CriticalMedicine. We're not asking for privileges—we're asking for access to treatment that makes a difference for people with #VonWillebrandDisease. It's about equity and social justice. 🩸

@ema.europa.eu

Supply delays of Von Willebrand Factor can cause severe consequences for #VonWillebrandDisease patients - worsening health, irreversible damage, hospitalisations, even death. Health systems must recognise #VonWillebrandFactor as #CriticalMedicine.

@ema.europa.eu

#VonWillebrandDisease can be the cause of unexplained abnormal uterine bleeding with severe chronic anaemia and iron deficiency.

It’s time for health systems to recognise #VonWillebrandFactor as a #CriticalMedicine.

@ema.europa.eu

#VonWillebrandDisease affects 1:1000 individuals and, if not recognised, may cause severe bleeding symptoms after trauma or surgery that can be life-threatening.

It’s time for health systems to recognise #VonWillebrandFactor as a #CriticalMedicine.

@ema.europa.eu

#MedSky🧪#NeuroSky #Criticalmedicine #ICU In this study @nejm.org the
patients with aneurysmal subarachnoid hemorrhage & anemia, a liberal transfusion strategy did not result in a lower risk of an unfavorable neurologic outcome at 12 months than a restrictive strategy …